カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のチモシンβ-4市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Thymosin beta-4 Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19662）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19662
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：94
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のチモシンβ-4市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

チモシンβ-4市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のチモシンβ-4の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

チモシンβ-4市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・皮膚修復、ドライアイ、角膜損傷、心筋損傷、脳損傷、その他

用途別セグメントは次のように区分されます。
・人間、動物

世界のチモシンβ-4市場の主要な市場プレーヤーは以下のとおりです。
・Bio-Techne、Merck、Phoenix Pharmaceuticals、Santa Cruz Biotechnology, Inc、Prospec-Tany Technogene Ltd、PeproTech、Shaanxi Hongbaiyi Biotech Co、Beijing Northland

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、チモシンβ-4製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なチモシンβ-4メーカーの企業概要、2019年～2022年までのチモシンβ-4の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なチモシンβ-4メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別チモシンβ-4の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのチモシンβ-4の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのチモシンβ-4市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびチモシンβ-4の産業チェーンを掲載しています。
・第13、14、15章では、チモシンβ-4の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- チモシンβ-4の概要
- 種類別分析（2017年vs2021年vs2028年）：皮膚修復、ドライアイ、角膜損傷、心筋損傷、脳損傷、その他
- 用途別分析（2017年vs2021年vs2028年）：人間、動物
- 世界のチモシンβ-4市場規模・予測
- 世界のチモシンβ-4生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Bio-Techne、Merck、Phoenix Pharmaceuticals、Santa Cruz Biotechnology, Inc、Prospec-Tany Technogene Ltd、PeproTech、Shaanxi Hongbaiyi Biotech Co、Beijing Northland
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：皮膚修復、ドライアイ、角膜損傷、心筋損傷、脳損傷、その他
・用途別分析2017年-2028年：人間、動物
・チモシンβ-4の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・チモシンβ-4のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・チモシンβ-4のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・チモシンβ-4の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・チモシンβ-4の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Thymosin beta-4 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Thymosin beta-4 market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Human accounting for % of the Thymosin beta-4 global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Skin Repair segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Thymosin beta-4 include Bio-Techne, Merck, Phoenix Pharmaceuticals, Santa Cruz Biotechnology, Inc, and Prospec-Tany Technogene Ltd, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Thymosin beta-4 market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Skin Repair
Dry Eye
Corneal Injury
Myocardial Injury
Brain Injury
Others
Market segment by Application can be divided into
Human
Animal
The key market players for global Thymosin beta-4 market are listed below:
Bio-Techne
Merck
Phoenix Pharmaceuticals
Santa Cruz Biotechnology, Inc
Prospec-Tany Technogene Ltd
PeproTech
Shaanxi Hongbaiyi Biotech Co
Beijing Northland
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Thymosin beta-4 product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Thymosin beta-4, with price, sales, revenue and global market share of Thymosin beta-4 from 2019 to 2022.
Chapter 3, the Thymosin beta-4 competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Thymosin beta-4 breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Thymosin beta-4 market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Thymosin beta-4.
Chapter 13, 14, and 15, to describe Thymosin beta-4 sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Thymosin beta-4 Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Thymosin beta-4 Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Skin Repair
1.2.3 Dry Eye
1.2.4 Corneal Injury
1.2.5 Myocardial Injury
1.2.6 Brain Injury
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Thymosin beta-4 Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Human
1.3.3 Animal
1.4 Global Thymosin beta-4 Market Size & Forecast
1.4.1 Global Thymosin beta-4 Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Thymosin beta-4 Sales in Volume (2017-2028)
1.4.3 Global Thymosin beta-4 Price (2017-2028)
1.5 Global Thymosin beta-4 Production Capacity Analysis
1.5.1 Global Thymosin beta-4 Total Production Capacity (2017-2028)
1.5.2 Global Thymosin beta-4 Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Thymosin beta-4 Market Drivers
1.6.2 Thymosin beta-4 Market Restraints
1.6.3 Thymosin beta-4 Trends Analysis
2 Manufacturers Profiles
2.1 Bio-Techne
2.1.1 Bio-Techne Details
2.1.2 Bio-Techne Major Business
2.1.3 Bio-Techne Thymosin beta-4 Product and Services
2.1.4 Bio-Techne Thymosin beta-4 Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Thymosin beta-4 Product and Services
2.2.4 Merck Thymosin beta-4 Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Phoenix Pharmaceuticals
2.3.1 Phoenix Pharmaceuticals Details
2.3.2 Phoenix Pharmaceuticals Major Business
2.3.3 Phoenix Pharmaceuticals Thymosin beta-4 Product and Services
2.3.4 Phoenix Pharmaceuticals Thymosin beta-4 Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Santa Cruz Biotechnology, Inc
2.4.1 Santa Cruz Biotechnology, Inc Details
2.4.2 Santa Cruz Biotechnology, Inc Major Business
2.4.3 Santa Cruz Biotechnology, Inc Thymosin beta-4 Product and Services
2.4.4 Santa Cruz Biotechnology, Inc Thymosin beta-4 Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Prospec-Tany Technogene Ltd
2.5.1 Prospec-Tany Technogene Ltd Details
2.5.2 Prospec-Tany Technogene Ltd Major Business
2.5.3 Prospec-Tany Technogene Ltd Thymosin beta-4 Product and Services
2.5.4 Prospec-Tany Technogene Ltd Thymosin beta-4 Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 PeproTech
2.6.1 PeproTech Details
2.6.2 PeproTech Major Business
2.6.3 PeproTech Thymosin beta-4 Product and Services
2.6.4 PeproTech Thymosin beta-4 Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Shaanxi Hongbaiyi Biotech Co
2.7.1 Shaanxi Hongbaiyi Biotech Co Details
2.7.2 Shaanxi Hongbaiyi Biotech Co Major Business
2.7.3 Shaanxi Hongbaiyi Biotech Co Thymosin beta-4 Product and Services
2.7.4 Shaanxi Hongbaiyi Biotech Co Thymosin beta-4 Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Beijing Northland
2.8.1 Beijing Northland Details
2.8.2 Beijing Northland Major Business
2.8.3 Beijing Northland Thymosin beta-4 Product and Services
2.8.4 Beijing Northland Thymosin beta-4 Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Thymosin beta-4 Breakdown Data by Manufacturer
3.1 Global Thymosin beta-4 Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Thymosin beta-4 Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Thymosin beta-4
3.4 Market Concentration Rate
3.4.1 Top 3 Thymosin beta-4 Manufacturer Market Share in 2021
3.4.2 Top 6 Thymosin beta-4 Manufacturer Market Share in 2021
3.5 Global Thymosin beta-4 Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Thymosin beta-4 Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Thymosin beta-4 Market Size by Region
4.1.1 Global Thymosin beta-4 Sales in Volume by Region (2017-2028)
4.1.2 Global Thymosin beta-4 Revenue by Region (2017-2028)
4.2 North America Thymosin beta-4 Revenue (2017-2028)
4.3 Europe Thymosin beta-4 Revenue (2017-2028)
4.4 Asia-Pacific Thymosin beta-4 Revenue (2017-2028)
4.5 South America Thymosin beta-4 Revenue (2017-2028)
4.6 Middle East and Africa Thymosin beta-4 Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Thymosin beta-4 Sales in Volume by Type (2017-2028)
5.2 Global Thymosin beta-4 Revenue by Type (2017-2028)
5.3 Global Thymosin beta-4 Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Thymosin beta-4 Sales in Volume by Application (2017-2028)
6.2 Global Thymosin beta-4 Revenue by Application (2017-2028)
6.3 Global Thymosin beta-4 Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Thymosin beta-4 Sales by Type (2017-2028)
7.2 North America Thymosin beta-4 Sales by Application (2017-2028)
7.3 North America Thymosin beta-4 Market Size by Country
7.3.1 North America Thymosin beta-4 Sales in Volume by Country (2017-2028)
7.3.2 North America Thymosin beta-4 Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Thymosin beta-4 Sales by Type (2017-2028)
8.2 Europe Thymosin beta-4 Sales by Application (2017-2028)
8.3 Europe Thymosin beta-4 Market Size by Country
8.3.1 Europe Thymosin beta-4 Sales in Volume by Country (2017-2028)
8.3.2 Europe Thymosin beta-4 Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Thymosin beta-4 Sales by Type (2017-2028)
9.2 Asia-Pacific Thymosin beta-4 Sales by Application (2017-2028)
9.3 Asia-Pacific Thymosin beta-4 Market Size by Region
9.3.1 Asia-Pacific Thymosin beta-4 Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Thymosin beta-4 Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Thymosin beta-4 Sales by Type (2017-2028)
10.2 South America Thymosin beta-4 Sales by Application (2017-2028)
10.3 South America Thymosin beta-4 Market Size by Country
10.3.1 South America Thymosin beta-4 Sales in Volume by Country (2017-2028)
10.3.2 South America Thymosin beta-4 Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Thymosin beta-4 Sales by Type (2017-2028)
11.2 Middle East & Africa Thymosin beta-4 Sales by Application (2017-2028)
11.3 Middle East & Africa Thymosin beta-4 Market Size by Country
11.3.1 Middle East & Africa Thymosin beta-4 Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Thymosin beta-4 Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Thymosin beta-4 and Key Manufacturers
12.2 Manufacturing Costs Percentage of Thymosin beta-4
12.3 Thymosin beta-4 Production Process
12.4 Thymosin beta-4 Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Thymosin beta-4 Typical Distributors
13.3 Thymosin beta-4 Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Thymosin beta-4 Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Thymosin beta-4 Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Bio-Techne Basic Information, Manufacturing Base and Competitors
Table 4. Bio-Techne Major Business
Table 5. Bio-Techne Thymosin beta-4 Product and Services
Table 6. Bio-Techne Thymosin beta-4 Sales (g), Price (USD/100µg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Merck Basic Information, Manufacturing Base and Competitors
Table 8. Merck Major Business
Table 9. Merck Thymosin beta-4 Product and Services
Table 10. Merck Thymosin beta-4 Sales (g), Price (USD/100µg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Phoenix Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 12. Phoenix Pharmaceuticals Major Business
Table 13. Phoenix Pharmaceuticals Thymosin beta-4 Product and Services
Table 14. Phoenix Pharmaceuticals Thymosin beta-4 Sales (g), Price (USD/100µg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Santa Cruz Biotechnology, Inc Basic Information, Manufacturing Base and Competitors
Table 16. Santa Cruz Biotechnology, Inc Major Business
Table 17. Santa Cruz Biotechnology, Inc Thymosin beta-4 Product and Services
Table 18. Santa Cruz Biotechnology, Inc Thymosin beta-4 Sales (g), Price (USD/100µg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Prospec-Tany Technogene Ltd Basic Information, Manufacturing Base and Competitors
Table 20. Prospec-Tany Technogene Ltd Major Business
Table 21. Prospec-Tany Technogene Ltd Thymosin beta-4 Product and Services
Table 22. Prospec-Tany Technogene Ltd Thymosin beta-4 Sales (g), Price (USD/100µg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. PeproTech Basic Information, Manufacturing Base and Competitors
Table 24. PeproTech Major Business
Table 25. PeproTech Thymosin beta-4 Product and Services
Table 26. PeproTech Thymosin beta-4 Sales (g), Price (USD/100µg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Shaanxi Hongbaiyi Biotech Co Basic Information, Manufacturing Base and Competitors
Table 28. Shaanxi Hongbaiyi Biotech Co Major Business
Table 29. Shaanxi Hongbaiyi Biotech Co Thymosin beta-4 Product and Services
Table 30. Shaanxi Hongbaiyi Biotech Co Thymosin beta-4 Sales (g), Price (USD/100µg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Beijing Northland Basic Information, Manufacturing Base and Competitors
Table 32. Beijing Northland Major Business
Table 33. Beijing Northland Thymosin beta-4 Product and Services
Table 34. Beijing Northland Thymosin beta-4 Sales (g), Price (USD/100µg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Global Thymosin beta-4 Sales by Manufacturer (2019, 2020, 2021, and 2022) & (g)
Table 36. Global Thymosin beta-4 Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 37. Market Position of Manufacturers in Thymosin beta-4, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 38. Global Thymosin beta-4 Production Capacity by Company, (g): 2020 VS 2021
Table 39. Head Office and Thymosin beta-4 Production Site of Key Manufacturer
Table 40. Thymosin beta-4 New Entrant and Capacity Expansion Plans
Table 41. Thymosin beta-4 Mergers & Acquisitions in the Past Five Years
Table 42. Global Thymosin beta-4 Sales by Region (2017-2022) & (g)
Table 43. Global Thymosin beta-4 Sales by Region (2023-2028) & (g)
Table 44. Global Thymosin beta-4 Revenue by Region (2017-2022) & (USD Million)
Table 45. Global Thymosin beta-4 Revenue by Region (2023-2028) & (USD Million)
Table 46. Global Thymosin beta-4 Sales by Type (2017-2022) & (g)
Table 47. Global Thymosin beta-4 Sales by Type (2023-2028) & (g)
Table 48. Global Thymosin beta-4 Revenue by Type (2017-2022) & (USD Million)
Table 49. Global Thymosin beta-4 Revenue by Type (2023-2028) & (USD Million)
Table 50. Global Thymosin beta-4 Price by Type (2017-2022) & (USD/100µg)
Table 51. Global Thymosin beta-4 Price by Type (2023-2028) & (USD/100µg)
Table 52. Global Thymosin beta-4 Sales by Application (2017-2022) & (g)
Table 53. Global Thymosin beta-4 Sales by Application (2023-2028) & (g)
Table 54. Global Thymosin beta-4 Revenue by Application (2017-2022) & (USD Million)
Table 55. Global Thymosin beta-4 Revenue by Application (2023-2028) & (USD Million)
Table 56. Global Thymosin beta-4 Price by Application (2017-2022) & (USD/100µg)
Table 57. Global Thymosin beta-4 Price by Application (2023-2028) & (USD/100µg)
Table 58. North America Thymosin beta-4 Sales by Country (2017-2022) & (g)
Table 59. North America Thymosin beta-4 Sales by Country (2023-2028) & (g)
Table 60. North America Thymosin beta-4 Revenue by Country (2017-2022) & (USD Million)
Table 61. North America Thymosin beta-4 Revenue by Country (2023-2028) & (USD Million)
Table 62. North America Thymosin beta-4 Sales by Type (2017-2022) & (g)
Table 63. North America Thymosin beta-4 Sales by Type (2023-2028) & (g)
Table 64. North America Thymosin beta-4 Sales by Application (2017-2022) & (g)
Table 65. North America Thymosin beta-4 Sales by Application (2023-2028) & (g)
Table 66. Europe Thymosin beta-4 Sales by Country (2017-2022) & (g)
Table 67. Europe Thymosin beta-4 Sales by Country (2023-2028) & (g)
Table 68. Europe Thymosin beta-4 Revenue by Country (2017-2022) & (USD Million)
Table 69. Europe Thymosin beta-4 Revenue by Country (2023-2028) & (USD Million)
Table 70. Europe Thymosin beta-4 Sales by Type (2017-2022) & (g)
Table 71. Europe Thymosin beta-4 Sales by Type (2023-2028) & (g)
Table 72. Europe Thymosin beta-4 Sales by Application (2017-2022) & (g)
Table 73. Europe Thymosin beta-4 Sales by Application (2023-2028) & (g)
Table 74. Asia-Pacific Thymosin beta-4 Sales by Region (2017-2022) & (g)
Table 75. Asia-Pacific Thymosin beta-4 Sales by Region (2023-2028) & (g)
Table 76. Asia-Pacific Thymosin beta-4 Revenue by Region (2017-2022) & (USD Million)
Table 77. Asia-Pacific Thymosin beta-4 Revenue by Region (2023-2028) & (USD Million)
Table 78. Asia-Pacific Thymosin beta-4 Sales by Type (2017-2022) & (g)
Table 79. Asia-Pacific Thymosin beta-4 Sales by Type (2023-2028) & (g)
Table 80. Asia-Pacific Thymosin beta-4 Sales by Application (2017-2022) & (g)
Table 81. Asia-Pacific Thymosin beta-4 Sales by Application (2023-2028) & (g)
Table 82. South America Thymosin beta-4 Sales by Country (2017-2022) & (g)
Table 83. South America Thymosin beta-4 Sales by Country (2023-2028) & (g)
Table 84. South America Thymosin beta-4 Revenue by Country (2017-2022) & (USD Million)
Table 85. South America Thymosin beta-4 Revenue by Country (2023-2028) & (USD Million)
Table 86. South America Thymosin beta-4 Sales by Type (2017-2022) & (g)
Table 87. South America Thymosin beta-4 Sales by Type (2023-2028) & (g)
Table 88. South America Thymosin beta-4 Sales by Application (2017-2022) & (g)
Table 89. South America Thymosin beta-4 Sales by Application (2023-2028) & (g)
Table 90. Middle East & Africa Thymosin beta-4 Sales by Region (2017-2022) & (g)
Table 91. Middle East & Africa Thymosin beta-4 Sales by Region (2023-2028) & (g)
Table 92. Middle East & Africa Thymosin beta-4 Revenue by Region (2017-2022) & (USD Million)
Table 93. Middle East & Africa Thymosin beta-4 Revenue by Region (2023-2028) & (USD Million)
Table 94. Middle East & Africa Thymosin beta-4 Sales by Type (2017-2022) & (g)
Table 95. Middle East & Africa Thymosin beta-4 Sales by Type (2023-2028) & (g)
Table 96. Middle East & Africa Thymosin beta-4 Sales by Application (2017-2022) & (g)
Table 97. Middle East & Africa Thymosin beta-4 Sales by Application (2023-2028) & (g)
Table 98. Thymosin beta-4 Raw Material
Table 99. Key Manufacturers of Thymosin beta-4 Raw Materials
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Thymosin beta-4 Typical Distributors
Table 103. Thymosin beta-4 Typical Customers
List of Figures
Figure 1. Thymosin beta-4 Picture
Figure 2. Global Thymosin beta-4 Revenue Market Share by Type in 2021
Figure 3. Skin Repair
Figure 4. Dry Eye
Figure 5. Corneal Injury
Figure 6. Myocardial Injury
Figure 7. Brain Injury
Figure 8. Others
Figure 9. Global Thymosin beta-4 Revenue Market Share by Application in 2021
Figure 10. Human
Figure 11. Animal
Figure 12. Global Thymosin beta-4 Revenue, (USD Million) & (g): 2017 & 2021 & 2028
Figure 13. Global Thymosin beta-4 Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Thymosin beta-4 Sales (2017-2028) & (g)
Figure 15. Global Thymosin beta-4 Price (2017-2028) & (USD/100µg)
Figure 16. Global Thymosin beta-4 Production Capacity (2017-2028) & (g)
Figure 17. Global Thymosin beta-4 Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Thymosin beta-4 Market Drivers
Figure 19. Thymosin beta-4 Market Restraints
Figure 20. Thymosin beta-4 Market Trends
Figure 21. Global Thymosin beta-4 Sales Market Share by Manufacturer in 2021
Figure 22. Global Thymosin beta-4 Revenue Market Share by Manufacturer in 2021
Figure 23. Thymosin beta-4 Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Thymosin beta-4 Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Thymosin beta-4 Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Thymosin beta-4 Sales Market Share by Region (2017-2028)
Figure 27. Global Thymosin beta-4 Revenue Market Share by Region (2017-2028)
Figure 28. North America Thymosin beta-4 Revenue (2017-2028) & (USD Million)
Figure 29. Europe Thymosin beta-4 Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Thymosin beta-4 Revenue (2017-2028) & (USD Million)
Figure 31. South America Thymosin beta-4 Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Thymosin beta-4 Revenue (2017-2028) & (USD Million)
Figure 33. Global Thymosin beta-4 Sales Market Share by Type (2017-2028)
Figure 34. Global Thymosin beta-4 Revenue Market Share by Type (2017-2028)
Figure 35. Global Thymosin beta-4 Price by Type (2017-2028) & (USD/100µg)
Figure 36. Global Thymosin beta-4 Sales Market Share by Application (2017-2028)
Figure 37. Global Thymosin beta-4 Revenue Market Share by Application (2017-2028)
Figure 38. Global Thymosin beta-4 Price by Application (2017-2028) & (USD/100µg)
Figure 39. North America Thymosin beta-4 Sales Market Share by Type (2017-2028)
Figure 40. North America Thymosin beta-4 Sales Market Share by Application (2017-2028)
Figure 41. North America Thymosin beta-4 Sales Market Share by Country (2017-2028)
Figure 42. North America Thymosin beta-4 Revenue Market Share by Country (2017-2028)
Figure 43. United States Thymosin beta-4 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Thymosin beta-4 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Thymosin beta-4 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Thymosin beta-4 Sales Market Share by Type (2017-2028)
Figure 47. Europe Thymosin beta-4 Sales Market Share by Application (2017-2028)
Figure 48. Europe Thymosin beta-4 Sales Market Share by Country (2017-2028)
Figure 49. Europe Thymosin beta-4 Revenue Market Share by Country (2017-2028)
Figure 50. Germany Thymosin beta-4 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Thymosin beta-4 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Thymosin beta-4 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Thymosin beta-4 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Thymosin beta-4 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Thymosin beta-4 Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Thymosin beta-4 Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Thymosin beta-4 Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Thymosin beta-4 Revenue Market Share by Region (2017-2028)
Figure 59. China Thymosin beta-4 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Thymosin beta-4 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Thymosin beta-4 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Thymosin beta-4 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Thymosin beta-4 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Thymosin beta-4 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Thymosin beta-4 Sales Market Share by Type (2017-2028)
Figure 66. South America Thymosin beta-4 Sales Market Share by Application (2017-2028)
Figure 67. South America Thymosin beta-4 Sales Market Share by Country (2017-2028)
Figure 68. South America Thymosin beta-4 Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Thymosin beta-4 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Thymosin beta-4 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Thymosin beta-4 Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Thymosin beta-4 Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Thymosin beta-4 Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Thymosin beta-4 Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Thymosin beta-4 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Thymosin beta-4 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Thymosin beta-4 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Thymosin beta-4 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Thymosin beta-4 in 2021
Figure 80. Manufacturing Process Analysis of Thymosin beta-4
Figure 81. Thymosin beta-4 Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のピグメントブルー15:4市場2022年：市場規模予測（～2028年）
  • 世界のファブラザイム（アガルシダーゼベータ）市場2022年：市場規模予測（～2028年）
  • インターフェロンβ-1aのグローバル市場展望 2023年-2029年：充填済み注射器、粉末状
  • 世界のインターフェロンベータ-1b治療薬市場2022年：市場規模予測（～2028年）
  • 世界のベータ-2 ミクログロブリン (B2M)市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19662 )"世界のチモシンβ-4市場2022年：市場規模予測（～2028年）" (英文：Global Thymosin beta-4 Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。